Speech disorder can lead to brain disease savita thakur thakur16 Feb 2016 3:15 PM ISTU.S.: Apraxia, a problem with speech programming, can lead to neurodegenerative disease - a condition that affects neurons in the human brain, a study...
Cystic fibrosis patients surviving longer in Canada than US savita thakur thakur17 March 2017 4:02 PM ISTWASHINGTON - Canadians with cystic fibrosis survive about 10 years longer than Americans with the same genetic disease, according to startling new...
Tezepelumab designated as breakthrough therapy for Severe Asthma Vinay Singh singh11 Sept 2018 8:20 PM ISTThe U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma without an...
Fremanezumab is new FDA approved Migraine Prevention Drug Vinay Singh singh19 Sept 2018 8:15 PM ISTThe U.S.Food and Drug Administration (FDA) has approved AJOVYTM (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults,...
New Intravitreal implant approved for posterior segment Uveitis Vinay Singh singh17 Oct 2018 7:25 PM ISTThe U.S. Food and Drug Administration (FDA) has approved YUTIQ™ (fluocinolone acetonide intravitreal implant) for the treatment of chronic...
Vortioxetine improves SSRI-Induced Sexual Dysfunction Vinay Singh singh25 Oct 2018 7:28 PM ISTIn a new study, it has been found that Vortioxetine an antidepressant, improves SSRI-Induced Sexual Dysfunction.The U.S. Food and Drug Administration...
Xyrem Approved for Use in Pediatric Patients With Narcolepsy Vinay Singh singh3 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) approved supplemental new drug application (sNDA) for Xyrem® (sodium oxybate) oral solution to include an...
New topical lotion for Plaque Psoriasis coming soon Vinay Singh singh10 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) approved BYHALIA Lotion indicated for the topical treatment of plaque psoriasis in adult patients,...
FDA approves once-daily, inhalation solution for COPD Vinay Singh singh13 Nov 2018 7:28 PM ISTThe U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for YUPELRI (revefenacin) inhalation solution for the...
Breakthrough oral therapy for Suicidal Bipolar Depression : FDA Vinay Singh singh14 Nov 2018 8:10 PM ISTThe US Food and Drug Administration granted Breakthrough Therapy designation to NRX-101 for the treatment of severe bipolar depression with acute...
FDA approves Oralair for grass pollen-induced allergic rhinitis in kids Vinay Singh singh15 Nov 2018 8:20 PM ISTThe US Food and Drug Administration approved the extension of the indication for Oralair an allergy immunotherapy sublingual tablet, to treat patients...
FDA clears VNS Therapy for prevention of Cluster Headache Vinay Singh singh30 Nov 2018 7:25 PM ISTThe U.S Food and Drug Administration (FDA) issued clearance certification to gammaCore, a non-invasive vagus nerve stimulator (nVNS) therapy, for...
